Belgium· BE-AMP-SAM173476-00
Biclar IV 500 mg
A clarithromycin product containing clarithromycin lactobionate, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 19 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Clarithromycin is registered in 19 of 19 countries.
Countries holding a registration under ATC J01FA09 (clarithromycin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Clarithromycin · ATC J01FA09
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of clarithromycin costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.65 in Italy to $2.90 in Switzerland — a ×4.5 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Clarithromycin · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.90
- FR France$0.94
- IT Italy$0.65
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Clarithromycin Lactobionate
- Manufacturer
- Viatris Healthcare
- Country
- Belgium (BE)
- ATC code
- J01FA09
- ATC class
- Clarithromycin
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb0747493
- be_apb1375930EUR 16.15
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1085 interactions on record for clarithromycin.
Graded by severity as the source publishes them — 274 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clarithromycin · interactions on record
1085 records
- 274 severe
- 434 moderate
- 50 minor
- 256 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
71 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clarithromycin in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCLARITHROMYCIN HAMELNhameln pharma gmbh, Hameln
- IrelandClarithromycin 500 mg Powder for concentrate for solution for infusionNoridem Enterprises Limited
- GermanyClarithromycin EberthDr. Friedrich Eberth Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Clarithromycin Olikla
- Germany · Clarithromycin Eberth
- Italy · Macladin, Veclam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/13c8b252-ec0a-4a16-8bd6-597d449591da GET /v1/drugs/13c8b252-ec0a-4a16-8bd6-597d449591da?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Biclar IV 500 mg",
"name_fr": "Biclar IV 500 mg",
"name_nl": "Biclar IV 500 mg",
"amp_code": "SAM173476-00",
"strengths": [
"752.7000",
"752.7000",
"500.0000",
"500.0000"
],
"pack_count": 1,
"substances": [
"Clarithromycin Lactobionate",
"Clarithromycine",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Clarithromycin",
"authorisation_numbers": [
"BE173476"
]
}See everything about clarithromycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.